These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 19178925
1. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. Kamiyama H, Yoshii H, Tanaka Y, Sato H, Yamamoto N, Kubo Y. Virology; 2009 Mar 30; 386(1):23-31. PubMed ID: 19178925 [Abstract] [Full Text] [Related]
2. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Ablan S, Rawat SS, Viard M, Wang JM, Puri A, Blumenthal R. Virol J; 2006 Dec 22; 3():104. PubMed ID: 17187670 [Abstract] [Full Text] [Related]
3. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. Barrero-Villar M, Cabrero JR, Gordón-Alonso M, Barroso-González J, Alvarez-Losada S, Muñoz-Fernández MA, Sánchez-Madrid F, Valenzuela-Fernández A. J Cell Sci; 2009 Jan 01; 122(Pt 1):103-13. PubMed ID: 19066282 [Abstract] [Full Text] [Related]
4. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. Popik W, Alce TM, Au WC. J Virol; 2002 May 01; 76(10):4709-22. PubMed ID: 11967288 [Abstract] [Full Text] [Related]
5. Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection. Kubo Y, Yoshii H, Kamiyama H, Tominaga C, Tanaka Y, Sato H, Yamamoto N. Virology; 2008 May 25; 375(1):130-40. PubMed ID: 18295815 [Abstract] [Full Text] [Related]
6. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. Iyengar S, Schwartz DH, Hildreth JE. J Immunol; 1999 May 15; 162(10):6263-7. PubMed ID: 10229873 [Abstract] [Full Text] [Related]
7. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals. Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF. AIDS; 2008 Jul 31; 22(12):1425-31. PubMed ID: 18614865 [Abstract] [Full Text] [Related]
8. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Nguyen DH, Giri B, Collins G, Taub DD. Exp Cell Res; 2005 Apr 01; 304(2):559-69. PubMed ID: 15748900 [Abstract] [Full Text] [Related]
9. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen. Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G. Clin Infect Dis; 2008 May 15; 46(10):1617-23. PubMed ID: 18419499 [Abstract] [Full Text] [Related]
10. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S, Khalid M, Wesley C, Khan SA, Wanchu A, Jameel S. J Clin Virol; 2008 Sep 15; 43(1):25-31. PubMed ID: 18462992 [Abstract] [Full Text] [Related]
11. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. Moyle GJ, Wildfire A, Mandalia S, Mayer H, Goodrich J, Whitcomb J, Gazzard BG. J Infect Dis; 2005 Mar 15; 191(6):866-72. PubMed ID: 15717260 [Abstract] [Full Text] [Related]
12. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. Kozak SL, Heard JM, Kabat D. J Virol; 2002 Feb 15; 76(4):1802-15. PubMed ID: 11799176 [Abstract] [Full Text] [Related]
13. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4. BouHamdan M, Strayer DS, Wei D, Mukhtar M, Duan LX, Hoxie J, Pomerantz RJ. Gene Ther; 2001 Mar 15; 8(5):408-18. PubMed ID: 11313818 [Abstract] [Full Text] [Related]
14. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein. Lawson VA, Silburn KA, Gorry PR, Paukovic G, Purcell DF, Greenway AL, McPhee DA. Virology; 2004 Sep 15; 327(1):70-82. PubMed ID: 15327899 [Abstract] [Full Text] [Related]
15. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Wilkin TJ, Su Z, Kuritzkes DR, Hughes M, Flexner C, Gross R, Coakley E, Greaves W, Godfrey C, Skolnik PR, Timpone J, Rodriguez B, Gulick RM. Clin Infect Dis; 2007 Feb 15; 44(4):591-5. PubMed ID: 17243065 [Abstract] [Full Text] [Related]
16. Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4. Taub DD, Mikovits JA, Nilsson G, Schaffer EM, Key ML, Petrow-Sadowski C, Ruscetti FW. Cell Immunol; 2004 Aug 15; 230(2):65-80. PubMed ID: 15598422 [Abstract] [Full Text] [Related]
17. Constitutive association of cell surface CCR5 and CXCR4 in the presence of CD4. Wang J, Alvarez R, Roderiquez G, Guan E, Norcross MA. J Cell Biochem; 2004 Nov 01; 93(4):753-60. PubMed ID: 15660419 [Abstract] [Full Text] [Related]
18. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. Secchiero P, Zella D, Capitani S, Gallo RC, Zauli G. J Immunol; 1999 Feb 15; 162(4):2427-31. PubMed ID: 9973525 [Abstract] [Full Text] [Related]
19. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Grivel JC, Ito Y, Fagà G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L. Nat Med; 2001 Nov 15; 7(11):1232-5. PubMed ID: 11689888 [Abstract] [Full Text] [Related]
20. Enhanced infection of an X4 strain of HIV-1 due to capping and colocalization of CD4 and CXCR4 induced by capsianoside G, a diterpene glycoside. Song W, Yahara S, Maeda Y, Yusa K, Tanaka Y, Harada S. Biochem Biophys Res Commun; 2001 May 04; 283(2):423-9. PubMed ID: 11327719 [Abstract] [Full Text] [Related] Page: [Next] [New Search]